Xagenic to Receive up to $990K from Government of Canada

Xagenic Inc., a Toronto, Canada-based molecular diagnostics company, will receive up to $990k in funding from the Government of Canada.

The company will use the funds for the design and development of its lab-free platform which will enable widespread decentralized diagnostic testing to be performed outside of clinical testing laboratories.

The investment complements a recent $10M Series A venture capital round, which included investments from CTI Life Sciences Fund, the Ontario Emerging Technologies Fund (OETF) and QIAGEN N.V. (read here).



Join the discussion